We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/fca-2020-0066

The cryoballoon (CB) is a popular ablation technology used for pulmonary vein isolation. The fourth-generation CB, Arctic Front Advance PRO features a 40% shorter distal tip but retains the internal design from its second-generation predecessor. The Arctic Front Advance PRO and the second-generation CB demonstrated similar thermodynamic characteristics in a computational model. Several observational and retrospective studies established the acute safety and efficacy of the Arctic Front Advance PRO. Real-time electrical isolation was observed in 75–85% of pulmonary veins targeted with the Arctic Front Advance PRO resulting in shorter fluoroscopy and procedure times.

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

  • 1. Calkins H, Hindricks G, Cappato R et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Heart Rhythm 14(10), e445–e494 (2017).
  • 2. Kuck KH, Brugada J, Furnkranz A et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N. Engl. J. Med. 374(23), 2235–2245 (2016). •• Landmark paper demonstrating noninferiority between radiofrequency (RF) and cryoballoon (CB) ablation for treatment of paroxysmal atrial fibrillation.
  • 3. Dukkipati SR, Cuoco F, Kutinsky I et al. Pulmonary vein isolation using the visually guided laser balloon: a prospective, multicenter, and randomized comparison to standard radiofrequency ablation. J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
  • 4. De Pooter J, Strisciuglio T, El Haddad M et al. Pulmonary vein reconnection no longer occurs in the majority of patients after a single pulmonary vein isolation procedure. JACC Clin. Electrophysiol. 5(3), 295–305 (2019).
  • 5. Ciconte G, Velagic V, Mugnai G et al. Electrophysiological findings following pulmonary vein isolation using radiofrequency catheter guided by contact-force and second-generation cryoballoon: lessons from repeat ablation procedures. Europace 18(1), 71–77 (2016).
  • 6. Kuck KH, Albenque JP, Chun KJ et al. Repeat ablation for atrial fibrillation recurrence post cryoballoon or radiofrequency ablation in the FIRE AND ICE trial. Circ. Arrhythm. Electrophysiol. 12(6), e007247 (2019).
  • 7. Heeger CH, Phan HL, Meyer-Saraei R et al. Second-generation visually guided laser balloon ablation system for pulmonary vein isolation: learning curve, safety and efficacy - the MERLIN registry. Circ. J. 83(12), 2443–2451 (2019).
  • 8. Neuzil P, Schmidt B, Chun J, Al E. Performance of a 3rd generation visually-guided laser balloon catheter for pulmonary vein isolation: results of the X3 study. Heart Rhythm Society's (HRS) 40th Annual Scientific Sessions. San Francisco, CA, USA, 8–11 May 2019.
  • 9. Kottkamp H, Hindricks G, Ponisch C et al. Global multielectrode contact-mapping plus ablation with a single catheter in patients with atrial fibrillation: global AF study. J. Cardiovasc. Electrophysiol. 30(11), 2248–2255 (2019).
  • 10. Rottner L, Bellmann B, Lin T et al. Catheter ablation of atrial fibrillation: state of the art and future perspectives. Cardiol. Ther. doi:10.1007/s40119-019-00158-2 (2020) (Epub ahead of print).
  • 11. Kuck KH, Furnkranz A, Chun KR et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur. Heart J. 37(38), 2858–2865 (2016).
  • 12. Mortsell D, Arbelo E, Dagres N et al. Cryoballoon vs radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry. Europace 21(4), 581–589 (2019).
  • 13. Chun KRJ, Brugada J, Elvan A et al. The impact of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation on healthcare utilization and costs: an economic analysis from the FIRE AND ICE trial. J. Am. Heart Assoc. 6(8), (2017). https://doi.org/10.1161/JAHA.117.006043 • Data suggests that CB ablation is more cost effective than RF-based PV isolation (PVI).
  • 14. Wissner E, Heeger CH, Grahn H et al. One-year clinical success of a ‘no-bonus’ freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation. Europace 17(8), 1236–1240 (2015).
  • 15. Ciconte G, Sieira-Moret J, Hacioglu E et al. Single 3-minute versus double 4-minute freeze strategy for second-generation cryoballoon ablation: a single-center experience. J. Cardiovasc. Electrophysiol. 27(7), 796–803 (2016).
  • 16. Andrade JG, Champagne J, Dubuc M et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation 140(22), 1779–1788 (2019). •• Latest randomized trial reporting equivalence in outcome between CB and RF-based PVI.
  • 17. Chun KR, Stich M, Furnkranz A et al. Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial. Heart Rhythm 14(4), 495–500 (2017).
  • 18. Reissmann B, Wissner E, Deiss S et al. First insights into cryoballoon-based pulmonary vein isolation taking the individual time-to-isolation into account. Europace 19(10), 1676–1680 (2017).
  • 19. Aryana A, Kowalski M, O'neill PG et al. Catheter ablation using the third-generation cryoballoon provides an enhanced ability to assess time to pulmonary vein isolation facilitating the ablation strategy: short- and long-term results of a multicenter study. Heart Rhythm 13(12), 2306–2313 (2016).
  • 20. Heeger CH, Wissner E, Mathew S et al. Short tip-big difference? First-in-man experience and procedural efficacy of pulmonary vein isolation using the third-generation cryoballoon. Clin. Res. Cardiol. 105(6), 482–488 (2016).
  • 21. Aryana A, Kenigsberg DN, Kowalski M et al. Verification of a novel atrial fibrillation cryoablation dosing algorithm guided by time-to-pulmonary vein isolation: results from the Cryo-DOSING study (cryoballoon-ablation DOSING based on the assessment of time-to-effect and pulmonary vein isolation guidance). Heart Rhythm 14(9), 1319–1325 (2017). • An ablative strategy based on time to PVI resulted in shorter fluoroscopy and procedure times.
  • 22. Mugnai G, De Asmundis C, Hunuk B et al. Improved visualisation of real-time recordings during third generation cryoballoon ablation: a comparison between the novel short-tip and the second generation device. J. Interv. Card. Electrophysiol. 46(3), 307–314 (2016).
  • 23. Pott A, Petscher K, Messemer M, Rottbauer W, Dahme T. Increased rate of observed real-time pulmonary vein isolation with third-generation short-tip cryoballoon. J. Interv. Card. Electrophysiol. 47(3), 333–339 (2016).
  • 24. Furnkranz A, Bologna F, Bordignon S et al. Procedural characteristics of pulmonary vein isolation using the novel third-generation cryoballoon. Europace 18(12), 1795–1800 (2016).
  • 25. Getman MK, Wissner E, Ranjan R, Lalonde JP. Relationship between time-to-isolation and freeze duration: computational modeling of dosing for Arctic Front Advance and Arctic Front Advance Pro cryoballoons. J. Cardiovasc. Electrophysiol. 30(11), 2274–2282 (2019).
  • 26. Su W, Aryana A, Passman R et al. Cryoballoon best practices II: practical guide to procedural monitoring and dosing during atrial fibrillation ablation from the perspective of experienced users. Heart Rhythm 15(9), 1348–1355 (2018).
  • 27. Andrade JG. Cryoablation for atrial fibrillation. Heart Rhythm O 21(1), 44–58 (2020). • Up-to-date review on CB ablation.
  • 28. Chen S, Schmidt B, Bordignon S, Perrotta L, Bologna F, Chun KRJ. Impact of cryoballoon freeze duration on long-term durability of pulmonary vein isolation: ICE re-map study. JACC Clin. Electrophysiol. 5(5), 551–559 (2019). • Remapping demonstrated a lower rate of pulmonary vein reconnection using a 4- versus 3-min freeze application.
  • 29. Straube F, Dorwarth U, Pongratz J et al. The fourth cryoballoon generation with a shorter tip to facilitate real-time pulmonary vein potential recording: feasibility and safety results. J. Cardiovasc. Electrophysiol. 30(6), 918–925 (2019). • One of the first studies to demonstrate safety acute efficacy using the newest-generation CB.
  • 30. Rottner L, Mathew S, Reissmann B et al. Feasibility, safety, and acute efficacy of the fourth-generation cryoballoon for ablation of atrial fibrillation: another step forward? Clin. Cardiol. 43(4), 394–400 (2020).
  • 31. Moltrasio M, Sicuso R, Fassini GM et al. Acute outcome after a single cryoballoon ablation: comparison between Arctic Front Advance and Arctic Front Advance PRO. Pacing Clin. Electrophysiol. 42(7), 890–896 (2019).
  • 32. Iacopino S, Pieragnoli P, Arena G et al. A comparison of acute procedural outcomes within four generations of cryoballoon catheters utilized in the real-world multicenter experience of 1STOP. J. Cardiovasc. Electrophysiol. 31(1), 80–88 (2020).